Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,190,173 papers from all fields of science
Search
Sign In
Create Free Account
MK-0787
Known as:
MK 0787
, MK0787
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Imipenem
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1983
1983
Occurrence and expression of imipemide (N-formimidoyl thienamycin) resistance in clinical isolates of coagulase-negative staphylococci
R. Blumenthal
,
R. Raeder
,
C. Takemoto
,
E. Freimer
Antimicrobial Agents and Chemotherapy
1983
Corpus ID: 25758601
More than 500 clinical isolates were screened for resistance to a number of antibiotics, including imipemide (N-formimidoyl…
Expand
1982
1982
Comparative in-vitro activity of MK0787 (N-formimidoyl thienamycin) against 540 blood culture isolates.
D. Cohn
,
L. Reimer
,
L. Reller
Journal of Antimicrobial Chemotherapy
1982
Corpus ID: 39570090
1982
1982
Comparative activities of N-formimidoyl thienamycin, ticarcillin, and tobramycin against experimental Pseudomonas aeruginosa pneumonia
J. Pennington
,
C. Johnson
Antimicrobial Agents and Chemotherapy
1982
Corpus ID: 41251138
The therapeutic efficacies of disodium ticarcillin, tobramycin sulfate, and N-formimidoyl thienamycin (MK0787) were compared in…
Expand
1982
1982
In vitro activity and beta-lactamase stability of N-formimidoyl thienamycin compared to that of second and third generation cephalosporins.
A. Vuye
Chemotherapy
1982
Corpus ID: 20164335
N-Formimidoyl thienamycin (MK0787) was found to be active against 21 gram-negative isolates, selected for their beta-lactamase…
Expand
1982
1982
Cefoxitin, N-formimidoyl thienamycin, clavulanic acid, and penicillanic acid sulfone as suicide inhibitors for different types of beta-lactamases produced by gram-negative bacteria.
T. Sawai
,
K. Tsukamoto
Journal of antibiotics (Tokyo. )
1982
Corpus ID: 35208422
Cefoxitin, N-formimidoyl thienamycin (MK0787), clavulanic acid, and penicillanic acid sulfone (CP45,899) were studied to…
Expand
1982
1982
In vitro comparison of N-formimidoyl thienamycin (MK0787) and Azlocillin with three aminoglycosides and ticarcillin against Pseudomonas aeruginosa
A. Matzkowitz
,
A. Baltch
,
R. Smith
,
N. Sutphen
,
M. Hammer
,
J. Conroy
Antimicrobial Agents and Chemotherapy
1982
Corpus ID: 13050608
The activities of N-formimidoyl thienamycin and azlocillin were compared with those of tobramycin, gentamicin, amikacin, and…
Expand
1981
1981
N-Formimidoyl thienamycin (MK0787): in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.
D. Hanslo
,
A. King
,
K. Shannon
,
C. Warren
,
I. Phillips
Journal of Antimicrobial Chemotherapy
1981
Corpus ID: 11893196
1981
1981
In vitro activity of N-formimidoyl thienamycin (MK0787) against resistant strains of Pseudomonas aeruginosa, Staphylococcus epidermidis, Serratia marcescens, and Enterococcus spp
W. K. Livingston
,
A. Elliott
,
C. Cobbs
Antimicrobial Agents and Chemotherapy
1981
Corpus ID: 29047752
The in vitro activities of N-formimidoyl thienamycin (MK0787) and nine other antibiotics were tested against 129 clinical…
Expand
1981
1981
N-formimidoyl thienamycin (MK0787): in vitro study
S. Shadomy
,
R. May
Antimicrobial Agents and Chemotherapy
1981
Corpus ID: 38135583
N-Formimidoyl thienamycin (MK0787) was compared in vitro with three other beta-lactam and two aminoglycoside antibiotics. It was…
Expand
1980
1980
Effect of N-formimidoyl thienamycin (MK0787) on beta-lactamases and activity against beta-lactamase-producing strains
M. Toda
,
K. Sato
,
H. Nakazawa
,
M. Inoue
,
S. Mitsuhashi
Antimicrobial Agents and Chemotherapy
1980
Corpus ID: 22391338
N-Formimidoyl thienamycin (MK0787) was active against beta-lactamase-producing strains and was an effective inhibitor of beta…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE